---
title: 'Suitability of paediatric legislation beyond the USA and Europe: a qualitative
  study on access to paediatric medicines'
date: '2025-02-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/40018188/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250228171006&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The study findings suggest that paediatric legislation
  may be most impactful in mature health systems and should be accompanied by measures
  addressing access barriers beyond marketing registration. This could include strengthening
  domestic manufacturing capacities and technology transfer for medicines with high
  public health relevance. Ideally, legislative changes would build on global harmonisation
  of paediatric legislation, which could be achieved through existing WHO ...'
disable_comments: true
---
CONCLUSIONS: The study findings suggest that paediatric legislation may be most impactful in mature health systems and should be accompanied by measures addressing access barriers beyond marketing registration. This could include strengthening domestic manufacturing capacities and technology transfer for medicines with high public health relevance. Ideally, legislative changes would build on global harmonisation of paediatric legislation, which could be achieved through existing WHO ...